7-92102725-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_005751.5(AKAP9):āc.11229G>Cā(p.Met3743Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000713 in 1,613,990 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin Lovd.
Frequency
Consequence
NM_005751.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKAP9 | NM_005751.5 | c.11229G>C | p.Met3743Ile | missense_variant | 46/50 | ENST00000356239.8 | NP_005742.4 | |
AKAP9 | NM_147185.3 | c.11205G>C | p.Met3735Ile | missense_variant | 46/50 | NP_671714.1 | ||
AKAP9 | NM_001379277.1 | c.5874G>C | p.Met1958Ile | missense_variant | 25/29 | NP_001366206.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AKAP9 | ENST00000356239.8 | c.11229G>C | p.Met3743Ile | missense_variant | 46/50 | 1 | NM_005751.5 | ENSP00000348573.3 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152132Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251152Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135830
GnomAD4 exome AF: 0.0000732 AC: 107AN: 1461858Hom.: 0 Cov.: 32 AF XY: 0.0000688 AC XY: 50AN XY: 727238
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152132Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74318
ClinVar
Submissions by phenotype
Long QT syndrome 11 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 07, 2021 | - - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 573633). This missense change has been observed in individual(s) with clinical features of AKAP9-related conditions (PMID: 30276209, 30847666). This variant is present in population databases (rs143306820, gnomAD 0.01%). This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 3743 of the AKAP9 protein (p.Met3743Ile). - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 25, 2022 | The p.M3743I variant (also known as c.11229G>A), located in coding exon 46 of the AKAP9 gene, results from a G to A substitution at nucleotide position 11229. The methionine at codon 3743 is replaced by isoleucine, an amino acid with highly similar properties. This alteration has been reported (also noted as c.11229G>C) as a secondary cardiac variant in an exome cohort, in an atrial fibrillation cohort, in a cohort referred for suspicion of primary arrhythmia syndrome, in a cardiomyopathy/arrhythmia genetic testing cohort and in a left ventricular non-compaction (LVNC) cohort (Ng D et al. Circ Cardiovasc Genet. 2013;6:337-46; Doñate Puertas R et al. Biomed Res Int. 2018;2018:4862480; Adler A et al. Circ Arrhythm Electrophysiol. 2016;9:e003440; van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309; Richard P et al. Clin Genet, 2019 03;95:356-367). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at